List of investigational sleep drugs

[[List of Investigational Sleep Drugs

The development of sleep medications is an ongoing field of research, aiming to address various sleep disorders such as insomnia, sleep apnea, narcolepsy, and others. This article provides an overview of investigational sleep drugs that are currently under research or clinical trials but have not yet received approval for clinical use. The focus is on novel agents that promise to offer new mechanisms of action compared to existing therapies.

Investigational Drugs for Insomnia

Insomnia, characterized by difficulty falling asleep or staying asleep, is a common sleep disorder. The following investigational drugs are being studied for their potential to treat insomnia:

• Daridorexant - A dual orexin receptor antagonist that aims to inhibit the orexin system, which plays a key role in regulating the sleep-wake cycle.
• Lemborexant - Another dual orexin receptor antagonist, similar in action to daridorexant, but at different stages of clinical trials.
• Suvorexant - This drug is also an orexin receptor antagonist, focusing on blocking the signaling of orexin to promote sleep.

Investigational Drugs for Sleep Apnea

Sleep apnea is a disorder characterized by pauses in breathing or periods of shallow breathing during sleep. Investigational drugs for sleep apnea include:

• ADX-N05 - A novel compound being explored for its potential to treat excessive daytime sleepiness associated with sleep apnea.
• Solriamfetol - Stimulates the central nervous system and is under investigation for its ability to improve wakefulness in patients with sleep apnea.

Investigational Drugs for Narcolepsy

Narcolepsy is a long-term neurological disorder that involves a decreased ability to regulate sleep-wake cycles. Investigational drugs for narcolepsy include:

• Pitolisant - Acts as a histamine H3 receptor antagonist/inverse agonist, potentially improving wakefulness and reducing excessive daytime sleepiness.
• JZP-110 - Another central nervous system stimulant being studied for its efficacy in treating excessive daytime sleepiness in narcolepsy.

Other Investigational Sleep Drugs

There are also investigational drugs aimed at treating a broader range of sleep disorders or specific aspects of sleep:

• Tasimelteon - Targets the melatonin receptors, aiming to treat non-24-hour sleep-wake disorder, particularly in the blind.
• Ramelteon - Another drug targeting melatonin receptors, focusing on regulating the sleep-wake cycle more naturally.

Conclusion

The development of investigational sleep drugs is a dynamic area of research, with many compounds in various stages of clinical trials. These drugs offer hope for better treatment options for individuals suffering from sleep disorders, with mechanisms of action that differ from currently available medications.

This list is incomplete; you can help by expanding it.